Markets
← Back to Sector Map
COO
Health Care · Health Care SuppliesCOOPER COS INC/THE
$72.41
+0.98%
AI Research
Q1 revenue beats at $1.02B with raised full-year guidance; Needham raises target to $101
MixedHoldPT $101.00
Cooper Companies reported strong Q1 2026 revenue of $1.02B and raised full-year guidance, with Q4 2025 EPS of $1.15 beating estimates of $1.11 by 3.60%. Needham raised its price target to $101 from $99 on March 6, 2026, though Morgan Stanley maintained a Hold rating on March 11. The stock is trading near the bottom of its 52-week range at ~$69.92, with CooperVision and CooperSurgical as the two business segments driving diversified healthcare growth.
Key Stats
Market Cap$13.9B
P/E (TTM)35.3
Fwd P/E14.2
Beta1.03
Div Yield—
Prev Close$71.71
52-Week Range
$61.78$72.41$89.83